1-12 of 12
Françoise Isnard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Is Azacitidine (AZA) Really Effective in High Risk MDS Patients with Chromosome 7 Abnormalities (Abn 7)? Results of a Retrospective Study From the GFM and GESMD Registries

María Díez-Campelo, MD, PhD, Raphael Itzykson, Silvia M Rojas, Céline Berthon, MD, PhD, Elisa Luño, Odile Beyne-Rauzy, Jaime Perez-Oteyza, Norbert Vey, MD, PhD, Joan Bargay, Sophie Park, Teresa Cedena, Dominique Bordessoule, MD, PhD, Juan A Muñoz, Emmanuel Gyan, MD, PhD, Esperanza Such, Sorin Visanica, MD, Luis Benlloch, Stéphane de Botton, MD, PhD, Jesús M Hernández-Rivas, Shanti Ame, MD, Aspasia Stamatoullas, MD, Jacques Delaunay, MD, Celia Salanoubat, MD, Françoise Isnard, MD, Guillermo Sanz, Romain Guieze, MD, Consuelo Cañizo, MD, PhD, Pierre Fenaux, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1713.
https://doi.org/10.1182/blood.V120.21.1713.1713
Published: 2012
Journal Articles

Association of Deferasirox and Vitamin D Promotes Cell Differentiation and Improves Overall Survival in Acute Myeloid Leukemia (AML) Elderly Patients After Demethylating Agents Failure: A Retrospective Case Control Study

Etienne Paubelle, Felipe Suarez, MD, PhD, Florence Zylbersztejn, Celine Callens, PharmD PhD, Michael Dussiot, Marc Benhamou, Françoise Isnard, MD, Marie T Rubio, MD, PhD, Gandhi Damaj, Norbert C. Gorin, MD, PhD, Jean-Pierre Marolleau, MD, PhD, Ivan Cruz Moura, PhD, Olivier Hermine
Journal: Blood
Blood (2012) 120 (21): 3622.
https://doi.org/10.1182/blood.V120.21.3622.3622
Published: 2012
Journal Articles

Molecular Minimal Residual Disease After Induction Is Related to ABC Proteins' Activity and Associated with Survival in 26 Patients with NPM1 Mutated Acute Myeloid Leukemia

Pierre Hirsch, Ruoping Tang, Christophe Marzac, MD, Fanny Fava, Jean-Yves Perrot, Françoise Isnard, MD, Jean-Pierre Marie, Ollivier Legrand, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4909.
https://doi.org/10.1182/blood.V120.21.4909.4909
Published: 2012
Journal Articles

Interest of the Association Azacitidine-Lenalidomide As Front Line Therapy in High-Risk Myelodysplasia (MDS) or Acute Myeloid Leukemia (AML) with Complex Karyotype

Elodie Scherman, Sandra Malak, MD, Christine Perot, MD, Norbert C. Gorin, MD, PhD, Marie T Rubio, MD, PhD, Françoise Isnard, MD
Journal: Blood
Blood (2011) 118 (21): 5035.
https://doi.org/10.1182/blood.V118.21.5035.5035
Published: 2011
Journal Articles

Mycological Diagnosis of Invasive Pulmonary Aspergillosis Should Depend on Both the Underlying Condition and the Neutropenia Status of Patients with Hematologic Malignancies

Anne Bergeron, MD, PhD, Raphaël Porcher, PhD, Annie Sulahian, PhD, Cédrid de Bazelaire, MD, PhD, Karine Chagnon, MD, Claire Lacroix, PhD, Emmanuel Raffoux, MD, Françoise Isnard, MD, Jean-Louis Poirot, PhD, Anne Vekhoff, Claire Bouges-Michel, PhD, Abdellatif Tazi, MD, PhD, Patricia Ribaud
Journal: Blood
Blood (2010) 116 (21): 1243.
https://doi.org/10.1182/blood.V116.21.1243.1243
Published: 2010
Journal Articles

A Prognostic Score for Overall Survival (OS) with Azacitidine (AZA) In Higher Risk MDS Based on 282 Patients (pts), and Validated In 175 Pts From the AZA 001 Trial

Raphael Itzykson, Sylvain Thepot, Bruno Quesnel, Francois Dreyfus, Odile Beyne-Rauzy, Pascal Turlure, Christian Recher, Caroline Dartigeas, Norbert Vey, MD, Laurence Legros, Jacques Delaunay, Celia Salanoubat, Sorin Visanica, Aspasia Stamatoullas, Françoise Isnard, MD, Anne Marfaing-Koka, Stephane De Botton, Youcef Chelgoum, Anne-Laure Taksin, Isabelle Plantier, Shanti Ame, Simone Boehrer, Claude Gardin, CL Beach, PharmD, Lionel Ades, Pierre Fenaux, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3996.
https://doi.org/10.1182/blood.V116.21.3996.3996
Published: 2010
Journal Articles

Interim Results of A Randomized Phase II Trial of Azacitidine (AZA) +/− Epo In Lower Risk Myelodysplastic Syndrome (MDS) Resistant to An Erythropoietic Stimulating Agent (ESA) Alone

Simone Boehrer, MD, Odile Beyne-Rauzy, MD, Thomas Prebet, M.D., Ph.D., Sophie Park, MD, PhD, Agnès Guerci, MD, Aspasia Stamatoulas, MD, MP Chaury, MD, Tony Jernival, Laurence Sanhes, MD, Gerard Tertian, MD, Stephane Cheze, MD, Eng-Mong Lim, Bachra Choufi, MD, Denis Caillot, MD, E. Wattel, MD, Jacques Delaunay, MD, Laurence Legros, MD, Fatiha Chermat, Françoise Isnard, MD, N. Cambier, MD, Borhane Slama, MD, Lydia Roy, MD, Gandhi Damaj, MD, Emmanuel Raffoux, MD, Francois Dreyfus, MD, Christian Récher, MD, Norbert Vey, MD, Sylvie Chevret, PhD, Pierre Fenaux, MD, PhD, Claude Gardin, MD
Journal: Blood
Blood (2010) 116 (21): 1880.
https://doi.org/10.1182/blood.V116.21.1880.1880
Published: 2010
Journal Articles

Treatment of AML with Azacytidine (AZA): Current Results of the French ATU Program.

Claire Fabre, MD, Claude Gardin, MD, Rose-Marie Mbida, Bruno Quesnel, MD, François Dreyfus, MD, Françoise Isnard, MD, Lionel Mannone, MD, Laurence Legros, MD, Thomas Prebet, MD, Norbert Vey, MD, Odile Beyne-Rauzy, MD, Florence Dalbies, MD, Stéphane Cheze, MD, Jacques Delaunay, MD, Christophe Fruchart, MD, Anne Marfaing-Koka, MD, Aspasia Stamatoullas, MD, Dominique Bordessoule, MD, Nathalie Cambier, MD, Jérôme Cornillon, MD, Caroline Dartigeas, MD, Béatrice Delmas-Marsalet, MD, Pierre Fenaux, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1849.
https://doi.org/10.1182/blood.V110.11.1849.1849
Published: 2007
Journal Articles

Treatment of High Risk MDS and AML Post-MDS with Azacytidine (AZA): Preliminary Results of the French ATU Program.

Claire Fabre, MD, Fatsiha Chermat, Laurence Legros, MD, Sophie Park, MD, François Dreyfus, MD, Françoise Isnard, MD, Florence Nowak, MD, Anne Marfaing, MD, Stéphane de Botton, MD, Marie-Pierre Noel, MD, Christophe Fruchart, MD, Thomas Prebet, MD, Norbert Vey, MD, Caroline Dartigeas, MD, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2006) 108 (11): 2664.
https://doi.org/10.1182/blood.V108.11.2664.2664
Published: 2006
Journal Articles

Study of V617F JAK2-Positive and JAK2-Negative Patients within 18 Families with Myeloproliferative Disorders (MPD): Disease Characteristics and Evolution, EPOR and MPL Analysis.

Christine Bellanne-Chantelot, PharmD,PhD, Myriam Labopin, M.D., Florence Bellanger, Isabelle Chaumarel, Françoise Isnard, M.D., Nicole Casadevall, M.D., William Vainchenker, M.D.,Ph.D., Gilles Thomas, M.D.,Ph.D., Albert Najman, M.D., the French Group on Familial MPD
Journal: Blood
Blood (2006) 108 (11): 672.
https://doi.org/10.1182/blood.V108.11.672.672
Published: 2006
Journal Articles

Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly with Imatinib Mesylate (STI571) and Chemotherapy.

Andre Delannoy, MD, Véronique Lhéritier, Xavier Thomas, MD, Sylvie Castaigne, MD, Françoise Rigal-Huguet, MD, Emmanuel Raffoux, MD, Frederic Garban, MD, Ollivier Legrand, MD, Francis Witz, MD, Viviane Dubruille, MD, Pascal Turlure, MD, Xavier Troussard, MD, Martine Delain, MD, Françoise Isnard, MD, Diane Coso, MD, Pascale Raby, MD, Agnès Buzyn, MD, Sylvie Caillères, MD, Stéphane Darre, MD, Bruno Lioure, MD, Anne Sonet, MD, Chrystele Bilhou-Nabera, MD, Marie-Christine Bene, MD, Elizabeth Macintyre, MD, Eric Delabesse, MD, Jean-Paul Vernant, MD, Norbert Ifrah, MD, Hervé Dombret, MD, Patrice Berthaud, MD, Denis Fière, MD
Journal: Blood
Blood (2005) 106 (11): 146.
https://doi.org/10.1182/blood.V106.11.146.146
Published: 2005
Journal Articles

Benefit of Early Switch to Liposomal Amphotericin B in Patients with Amphotericin B Deoxycholate-Induced Nephrotoxicity Versus Late Switch.

Françoise Isnard, Jean P. Laporte, Patrice Chevallier, Arnaud Pigneux, Patrick Tilleul, Antoine Lafuma, Lamine Mahi, Gilbert Deray
Journal: Blood
Blood (2005) 106 (11): 5381.
https://doi.org/10.1182/blood.V106.11.5381.5381
Published: 2005